ID FMOD_HUMAN Reviewed; 376 AA. AC Q06828; Q15331; Q8IV47; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 10-FEB-2009, sequence version 2. DT 27-MAR-2024, entry version 200. DE RecName: Full=Fibromodulin; DE Short=FM; DE AltName: Full=Collagen-binding 59 kDa protein; DE AltName: Full=Keratan sulfate proteoglycan fibromodulin; DE Short=KSPG fibromodulin; DE Flags: Precursor; GN Name=FMOD; Synonyms=FM, SLRR2E; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8357838; DOI=10.1016/0167-4781(93)90117-v; RA Antonsson P., Heinegaard D., Oldberg A.; RT "Structure and deduced amino acid sequence of the human fibromodulin RT gene."; RL Biochim. Biophys. Acta 1174:204-206(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=8093006; DOI=10.1042/bj3020527; RA Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., RA Border W.A., Ruoslahti E.; RT "Interaction of the small interstitial proteoglycans biglycan, decorin and RT fibromodulin with transforming growth factor beta."; RL Biochem. J. 302:527-534(1994). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP SULFATION AT TYR-20; TYR-38; TYR-39; TYR-45; TYR-47; TYR-53 AND TYR-55, RP LACK OF SULFATION AT TYR-63 AND TYR-65, PYROGLUTAMATE FORMATION AT GLN-19, RP AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=14551184; DOI=10.1074/jbc.m308689200; RA Onnerfjord P., Heathfield T.F., Heinegaard D.; RT "Identification of tyrosine sulfation in extracellular leucine-rich repeat RT proteins using mass spectrometry."; RL J. Biol. Chem. 279:26-33(2004). RN [8] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-201. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). CC -!- FUNCTION: Affects the rate of fibrils formation. May have a primary CC role in collagen fibrillogenesis (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Binds to type I and type II collagen. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix. CC -!- PTM: Binds keratan sulfate chains. {ECO:0000269|PubMed:14551184}. CC -!- SIMILARITY: Belongs to the small leucine-rich proteoglycan (SLRP) CC family. SLRP class II subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X72913; CAA51418.1; -; Genomic_DNA. DR EMBL; X75546; CAA53233.1; -; mRNA. DR EMBL; AK291632; BAF84321.1; -; mRNA. DR EMBL; AL359837; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471067; EAW91477.1; -; Genomic_DNA. DR EMBL; BC035281; AAH35281.1; -; mRNA. DR CCDS; CCDS30976.1; -. DR PIR; S55275; S55275. DR RefSeq; NP_002014.2; NM_002023.4. DR PDB; 5MX0; X-ray; 2.21 A; A/B=18-376. DR PDBsum; 5MX0; -. DR AlphaFoldDB; Q06828; -. DR SMR; Q06828; -. DR BioGRID; 108618; 48. DR IntAct; Q06828; 5. DR MINT; Q06828; -. DR STRING; 9606.ENSP00000347041; -. DR GlyConnect; 1242; 54 N-Linked glycans (3 sites). DR GlyCosmos; Q06828; 6 sites, 64 glycans. DR GlyGen; Q06828; 7 sites, 62 N-linked glycans (3 sites), 2 O-linked glycans (1 site). DR iPTMnet; Q06828; -. DR PhosphoSitePlus; Q06828; -. DR BioMuta; FMOD; -. DR DMDM; 223590208; -. DR jPOST; Q06828; -. DR MassIVE; Q06828; -. DR PaxDb; 9606-ENSP00000347041; -. DR PeptideAtlas; Q06828; -. DR ProteomicsDB; 58485; -. DR Antibodypedia; 34544; 317 antibodies from 28 providers. DR DNASU; 2331; -. DR Ensembl; ENST00000354955.5; ENSP00000347041.4; ENSG00000122176.12. DR GeneID; 2331; -. DR KEGG; hsa:2331; -. DR MANE-Select; ENST00000354955.5; ENSP00000347041.4; NM_002023.5; NP_002014.2. DR UCSC; uc001gzr.5; human. DR AGR; HGNC:3774; -. DR CTD; 2331; -. DR DisGeNET; 2331; -. DR GeneCards; FMOD; -. DR HGNC; HGNC:3774; FMOD. DR HPA; ENSG00000122176; Low tissue specificity. DR MIM; 600245; gene. DR neXtProt; NX_Q06828; -. DR OpenTargets; ENSG00000122176; -. DR PharmGKB; PA28190; -. DR VEuPathDB; HostDB:ENSG00000122176; -. DR eggNOG; KOG0619; Eukaryota. DR GeneTree; ENSGT00940000157007; -. DR HOGENOM; CLU_000288_186_4_1; -. DR InParanoid; Q06828; -. DR OMA; KLLYVRM; -. DR OrthoDB; 521898at2759; -. DR PhylomeDB; Q06828; -. DR TreeFam; TF334562; -. DR PathwayCommons; Q06828; -. DR Reactome; R-HSA-2022854; Keratan sulfate biosynthesis. DR Reactome; R-HSA-2022857; Keratan sulfate degradation. DR Reactome; R-HSA-3000178; ECM proteoglycans. DR Reactome; R-HSA-3656225; Defective CHST6 causes MCDC1. DR Reactome; R-HSA-3656243; Defective ST3GAL3 causes MCT12 and EIEE15. DR Reactome; R-HSA-3656244; Defective B4GALT1 causes B4GALT1-CDG (CDG-2d). DR SignaLink; Q06828; -. DR BioGRID-ORCS; 2331; 5 hits in 1144 CRISPR screens. DR ChiTaRS; FMOD; human. DR GeneWiki; FMOD_(gene); -. DR GenomeRNAi; 2331; -. DR Pharos; Q06828; Tbio. DR PRO; PR:Q06828; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q06828; Protein. DR Bgee; ENSG00000122176; Expressed in calcaneal tendon and 173 other cell types or tissues. DR ExpressionAtlas; Q06828; baseline and differential. DR GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL. DR GO; GO:0031012; C:extracellular matrix; TAS:ProtInc. DR GO; GO:0005576; C:extracellular region; HDA:BHF-UCL. DR GO; GO:0005615; C:extracellular space; HDA:BHF-UCL. DR GO; GO:0005796; C:Golgi lumen; TAS:Reactome. DR GO; GO:0043202; C:lysosomal lumen; TAS:Reactome. DR GO; GO:0030199; P:collagen fibril organization; IEA:Ensembl. DR GO; GO:0007181; P:transforming growth factor beta receptor complex assembly; TAS:ProtInc. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 3. DR InterPro; IPR001611; Leu-rich_rpt. DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR InterPro; IPR000372; LRRNT. DR PANTHER; PTHR45712; AGAP008170-PA; 1. DR PANTHER; PTHR45712:SF4; FIBROMODULIN; 1. DR Pfam; PF00560; LRR_1; 1. DR Pfam; PF13516; LRR_6; 1. DR Pfam; PF13855; LRR_8; 2. DR Pfam; PF01462; LRRNT; 1. DR SMART; SM00364; LRR_BAC; 5. DR SMART; SM00369; LRR_TYP; 8. DR SMART; SM00013; LRRNT; 1. DR SUPFAM; SSF52058; L domain-like; 1. DR PROSITE; PS51450; LRR; 10. DR Genevisible; Q06828; HS. PE 1: Evidence at protein level; KW 3D-structure; Disulfide bond; Extracellular matrix; Glycoprotein; KW Leucine-rich repeat; Proteoglycan; Pyrrolidone carboxylic acid; KW Reference proteome; Repeat; Secreted; Signal; Sulfation. FT SIGNAL 1..18 FT /evidence="ECO:0000250" FT CHAIN 19..376 FT /note="Fibromodulin" FT /id="PRO_0000032739" FT DOMAIN 67..105 FT /note="LRRNT" FT REPEAT 106..127 FT /note="LRR 1" FT REPEAT 130..151 FT /note="LRR 2" FT REPEAT 156..176 FT /note="LRR 3" FT REPEAT 177..198 FT /note="LRR 4" FT REPEAT 201..222 FT /note="LRR 5" FT REPEAT 224..245 FT /note="LRR 6" FT REPEAT 246..266 FT /note="LRR 7" FT REPEAT 269..289 FT /note="LRR 8" FT REPEAT 294..315 FT /note="LRR 9" FT REPEAT 316..335 FT /note="LRR 10" FT REPEAT 344..365 FT /note="LRR 11" FT SITE 63 FT /note="Not sulfated" FT /evidence="ECO:0000269|PubMed:14551184" FT SITE 65 FT /note="Not sulfated" FT /evidence="ECO:0000269|PubMed:14551184" FT MOD_RES 19 FT /note="Pyrrolidone carboxylic acid" FT /evidence="ECO:0000269|PubMed:14551184" FT MOD_RES 20 FT /note="Sulfotyrosine" FT /evidence="ECO:0000269|PubMed:14551184" FT MOD_RES 38 FT /note="Sulfotyrosine" FT /evidence="ECO:0000305|PubMed:14551184" FT MOD_RES 39 FT /note="Sulfotyrosine" FT /evidence="ECO:0000305|PubMed:14551184" FT MOD_RES 45 FT /note="Sulfotyrosine" FT /evidence="ECO:0000305|PubMed:14551184" FT MOD_RES 47 FT /note="Sulfotyrosine" FT /evidence="ECO:0000305|PubMed:14551184" FT MOD_RES 53 FT /note="Sulfotyrosine" FT /evidence="ECO:0000269|PubMed:14551184" FT MOD_RES 55 FT /note="Sulfotyrosine" FT /evidence="ECO:0000269|PubMed:14551184" FT CARBOHYD 127 FT /note="N-linked (GlcNAc...) (keratan sulfate) asparagine" FT /evidence="ECO:0000250" FT CARBOHYD 166 FT /note="N-linked (GlcNAc...) (keratan sulfate) asparagine" FT /evidence="ECO:0000250" FT CARBOHYD 201 FT /note="N-linked (GlcNAc...) (keratan sulfate) asparagine" FT /evidence="ECO:0000250" FT CARBOHYD 291 FT /note="N-linked (GlcNAc...) (keratan sulfate) asparagine" FT /evidence="ECO:0000250" FT CARBOHYD 341 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 334..367 FT /evidence="ECO:0000250" FT CONFLICT 4 FT /note="T -> A (in Ref. 2; CAA53233)" FT /evidence="ECO:0000305" FT CONFLICT 87 FT /note="P -> L (in Ref. 2; CAA53233)" FT /evidence="ECO:0000305" FT CONFLICT 210 FT /note="N -> D (in Ref. 2; CAA53233)" FT /evidence="ECO:0000305" FT CONFLICT 226 FT /note="I -> Y (in Ref. 1; CAA51418)" FT /evidence="ECO:0000305" FT CONFLICT 344 FT /note="K -> Q (in Ref. 1; CAA51418)" FT /evidence="ECO:0000305" FT CONFLICT 348 FT /note="L -> V (in Ref. 1; CAA51418 and 2; CAA53233)" FT /evidence="ECO:0000305" FT CONFLICT 355 FT /note="I -> M (in Ref. 1; CAA51418)" FT /evidence="ECO:0000305" FT CONFLICT 363 FT /note="D -> E (in Ref. 1; CAA51418)" FT /evidence="ECO:0000305" FT STRAND 89..91 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 108..111 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 122..125 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 133..135 FT /evidence="ECO:0007829|PDB:5MX0" FT HELIX 143..145 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 148..153 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 159..161 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 164..166 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 179..182 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 193..198 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 204..206 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 216..221 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 227..229 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 248..250 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 261..266 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 272..274 FT /evidence="ECO:0007829|PDB:5MX0" FT HELIX 282..284 FT /evidence="ECO:0007829|PDB:5MX0" FT TURN 287..290 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 297..299 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 317..319 FT /evidence="ECO:0007829|PDB:5MX0" FT HELIX 330..332 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 338..340 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 347..349 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 352..354 FT /evidence="ECO:0007829|PDB:5MX0" FT HELIX 357..359 FT /evidence="ECO:0007829|PDB:5MX0" FT HELIX 364..366 FT /evidence="ECO:0007829|PDB:5MX0" FT STRAND 373..375 FT /evidence="ECO:0007829|PDB:5MX0" SQ SEQUENCE 376 AA; 43179 MW; DC19D5E6724AB004 CRC64; MQWTSLLLLA GLFSLSQAQY EDDPHWWFHY LRSQQSTYYD PYDPYPYETY EPYPYGVDEG PAYTYGSPSP PDPRDCPQEC DCPPNFPTAM YCDNRNLKYL PFVPSRMKYV YFQNNQITSI QEGVFDNATG LLWIALHGNQ ITSDKVGRKV FSKLRHLERL YLDHNNLTRM PGPLPRSLRE LHLDHNQISR VPNNALEGLE NLTALYLQHN EIQEVGSSMR GLRSLILLDL SYNHLRKVPD GLPSALEQLY MEHNNVYTVP DSYFRGAPKL LYVRLSHNSL TNNGLASNTF NSSSLLELDL SYNQLQKIPP VNTNLENLYL QGNRINEFSI SSFCTVVDVV NFSKLQVLRL DGNEIKRSAM PADAPLCLRL ASLIEI //